SCHEMBL617183

SCHEMBL617183

CC(C)(C)OC(=O)N1CCN(Cc2ccc3cccc(O)c3n2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.47
TERT O14746 1/20 0.47
BCHE P06276 1/20 0.47
ACHE P22303 1/20 0.47
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.43
KDM1A O60341 1/20 0.43
VEGFA P15692 1/20 0.42
EGLN1 Q9GZT9 1/20 0.42
SMARCA2 P51531 1/20 0.42
SMARCA4 P51532 1/20 0.42
PBRM1 Q86U86 1/20 0.42
ACKR3 P25106 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23922807 0.80 GRM5 (0.51) TERTCHRM2CHRM4CHRM1CHRM3
SCHEMBL5595056 0.80 TERT (0.45) FAAHTERTVEGFAEGLN1SMARCA2
SCHEMBL465791 0.79 CHRM2 (0.47) TERTCHRM2CHRM4CHRM1CHRM3
SCHEMBL16061780 0.79 FAAH (0.58) FAAHTERTACHECHRM2CHRM4
SCHEMBL949354 0.79 CHRM2 (0.47) TERTCHRM2CHRM4CHRM1CHRM3
SCHEMBL25282066 0.78 CHRM4 (0.46) FAAHTERTCHRM2CHRM4CHRM1
SCHEMBL24695123 0.78 ALDH1A1 (0.45) TERTACHECHRM2CHRM4CHRM1
SCHEMBL22769224 0.77 CHRM2 (0.46) FAAHTERTACHECHRM2CHRM4
SCHEMBL22166944 0.76 ACHE (0.48) FAAHTERTBCHEACHECHRM2
SCHEMBL19013075 0.76 GRM5 (0.45) CHRM2CHRM4CHRM1CHRM3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8410110-B2 9-(piperazinylalkyl) carbazoles as Bax-modulators MERCK SERONO SA (CH) 2013-04-02 US disclosed
US-20120040933-A1 9-(PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040933-A1 9-(PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS BCL2, BAX, BAD FAAH 3763/4885TERT 4408/4885BCHE 3635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.